In FLT3-wt primary AML patient samples, combined treatment synergistically induced apoptosis in 3 of the 6 samples (though the magnitude of increase over single-drug treatment appears to be minimal), while antagonistic effects were detected in the other 3 samples (Fig. 3C). This evidence concerns the gene FLT3 and acute myeloid leukemia.